Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

WaveLight Inc.

BioPhotonics
Jun 2007
WaveLight Inc. of Sterling, Va., has announced FDA approval of wavefront-guided and mixed astigmatism indications for the company’s Allegretto Wave Eye-Q lasik system. The wavefront-guided procedure was approved for the reduction or elimination of up to –7 diopters of spherical equivalent of myopia or of myopia with astigmatism. The Eye-Q mixed astigmatism procedure was approved for the reduction or elimination of naturally occurring mixed astigmatism of up to 6 diopters at the spectacle plane. In both cases, patients must meet age and condition requirements.

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!